Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Chu

Showing results (91-100 of 211) with videos related to

Pageof 22
Sort By:
The Biochemical Journal|December 11, 2003
Characterization of a cis-acting regulatory element in the protein-coding region of human dihydrofolate reductase mRNANingwen Tai, John C Schmitz, Tian-min Chen, et al.
Clinical Colorectal Cancer|March 14, 2012
Reversible leukoencephalopathy with stroke-like presentation in a patient with 5-dihydropyrimidine dehydrogenase deficiency treated with continuous 5-fluorouracil infusionJia Li, James J Lee, Edward Chu, et al.
Clinical Colorectal Cancer|October 6, 2010
Patients with locally advanced and metastatic colorectal cancer treated with capecitabine versus 5-fluorouracil as monotherapy or combination therapy with oxaliplatin: a cost comparisonEdward Chu, Kathy L Schulman, Edward F McKenna, et al.
Clinical Colorectal Cancer|January 7, 2011
Safety and efficacy of panitumumab therapy after progression with cetuximab: experience at two institutionsMuhammad Wasif Saif, Kristin Kaley, Edward Chu, et al.
Journal of the National Cancer Institute|October 21, 2009
Pharmacokinetically guided dose adjustment of 5-fluorouracil: a rational approach to improving therapeutic outcomesM Wasif Saif, Adrienne Choma, Salvatore J Salamone, et al.
Journal of Biochemistry|June 6, 2006
Sequence analysis and functional study of thymidylate synthase from zebrafish, Danio rerioChangqing Du, Rongli Niu, Edward Chu, et al.
Organic Letters|July 12, 2011
Total synthesis of (-)-CP2-disorazole C1Chad D Hopkins, John C Schmitz, Edward Chu, et al.
Cancer Chemotherapy and Pharmacology|June 24, 2003
Thymidylate synthase inhibitors as anticancer agents: from bench to bedsideEdward Chu, Marc A Callender, Michael P Farrell, et al.
Current Oncology Reports|March 6, 2019
Cancer Biomarkers for Integrative OncologyAniruddha Ganguly, David Frank, Nagi Kumar, et al.
BMC Genomics|April 6, 2006
Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancerYaguang Xi, Go Nakajima, John C Schmitz, et al.
Pageof 22

Showing results (91-100 of 211) with videos related to

Sort By:
Pageof 22
The Biochemical Journal|December 11, 2003
Characterization of a cis-acting regulatory element in the protein-coding region of human dihydrofolate reductase mRNANingwen Tai, John C Schmitz, Tian-min Chen, et al.
Clinical Colorectal Cancer|March 14, 2012
Reversible leukoencephalopathy with stroke-like presentation in a patient with 5-dihydropyrimidine dehydrogenase deficiency treated with continuous 5-fluorouracil infusionJia Li, James J Lee, Edward Chu, et al.
Clinical Colorectal Cancer|October 6, 2010
Patients with locally advanced and metastatic colorectal cancer treated with capecitabine versus 5-fluorouracil as monotherapy or combination therapy with oxaliplatin: a cost comparisonEdward Chu, Kathy L Schulman, Edward F McKenna, et al.
Clinical Colorectal Cancer|January 7, 2011
Safety and efficacy of panitumumab therapy after progression with cetuximab: experience at two institutionsMuhammad Wasif Saif, Kristin Kaley, Edward Chu, et al.
Journal of the National Cancer Institute|October 21, 2009
Pharmacokinetically guided dose adjustment of 5-fluorouracil: a rational approach to improving therapeutic outcomesM Wasif Saif, Adrienne Choma, Salvatore J Salamone, et al.
Journal of Biochemistry|June 6, 2006
Sequence analysis and functional study of thymidylate synthase from zebrafish, Danio rerioChangqing Du, Rongli Niu, Edward Chu, et al.
Organic Letters|July 12, 2011
Total synthesis of (-)-CP2-disorazole C1Chad D Hopkins, John C Schmitz, Edward Chu, et al.
Cancer Chemotherapy and Pharmacology|June 24, 2003
Thymidylate synthase inhibitors as anticancer agents: from bench to bedsideEdward Chu, Marc A Callender, Michael P Farrell, et al.
Current Oncology Reports|March 6, 2019
Cancer Biomarkers for Integrative OncologyAniruddha Ganguly, David Frank, Nagi Kumar, et al.
BMC Genomics|April 6, 2006
Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancerYaguang Xi, Go Nakajima, John C Schmitz, et al.
Pageof 22